此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

REVASC-PAD:田纳西大学医学中心外周动脉疾病限制性血管运动可行性研究 (REVASC-PAD)

The purpose of this study is to evaluate the effects of Blood Flow Restriction (BFR) training on walking function, health-related quality of life, and safety among adults with Peripheral Arterial Disease (PAD).

The main aims of the study are:

  1. Evaluate change in walking function among patients with PAD undergoing BFR training. The investigators will assess change in Six-Minute Walk Test (6MWT) distance from baseline to post-intervention and 3-month follow-up to compare functional improvements between the BFR group and the two control groups
  2. Assess changes in health-related quality of life among patients with PAD undergoing BFR training. The investigators will use the EuroQol 5-Dimension 5-Level (EQ-5D-5L) scale to evaluate quality-of-life changes from baseline to post-intervention and 3-month follow-up across all study arms
  3. Evaluate the safety and feasibility of a supervised BFR training program for patients with PAD. The investigators will compare adverse event (AE) and serious adverse event (SAE) rates across study arms, while also monitoring sessional ratings of perceived exertion (RPE), dyspnea, and claudication pain as indicators of symptom response and exercise tolerance. Feasibility will be assessed through enrollment success, intervention adherence, and retention rates across groups

研究概览

研究类型

介入性

注册 (估计的)

81

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Tiffany Johnson, Study Coordinator
  • 电话号码:+1865-305-4682
  • 邮箱:thjohnson@utmck.edu

学习地点

    • Tennessee
      • Knoxville、Tennessee、美国、37920
        • 招聘中
        • University of Tennessee Medical Center
        • 首席研究员:
          • Morgan Randall, MD

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. 18 years of age or older
  2. Diagnosed peripheral arterial disease with stable claudication (symptomatic presentation unchanged for 6 months)
  3. Ankle-brachial index (ABI) between 0.4 and 0.9.
  4. Eligible referral to cardiovascular or pulmonary rehabilitation
  5. Prior revascularization permitted if symptoms are stable and other criteria are met

Exclusion Criteria:

  1. Recent change in resting ECG suggesting significant ischemia, recent myocardial infarction (within 2 weeks), or another acute cardiac event
  2. Unstable angina
  3. Uncontrolled cardiac arrhythmias
  4. Symptomatic severe aortic stenosis or other significant valvular disease
  5. Decompensated symptomatic heart failure
  6. Acute pulmonary embolism or infarction
  7. Acute noncardiac disorder likely to interfere with or be worsened by exercise (e.g., infection, thyrotoxicosis)
  8. Acute myocarditis or pericarditis
  9. Acute thrombophlebitis
  10. Physical disability precluding safe or adequate exercise performance
  11. Significant electrolyte abnormalities
  12. Clinically significant tachyarrhythmias or bradyarrhythmias
  13. High-degree atrioventricular block
  14. Atrial fibrillation with uncontrolled ventricular response
  15. Hypertrophic obstructive cardiomyopathy with resting left ventricular outflow gradient of >25 mmHg
  16. Known active aortic dissection
  17. Severe resting arterial hypertension (SBP>200mmHg or DBP >110 mmHg)
  18. Mental impairment preventing cooperation with study procedures
  19. Current pregnancy
  20. Moderate to severe peripheral neuropathy
  21. Open wounds or compromised skin near BFR cuff site
  22. Active DVT or thromboembolic event within the past year

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Blood Flow Restriction (BFR) Training

Participants perform supervised lower-body resistance training using pneumatic cuffs (Smart Cuff Pro or equivalent) applied to the proximal thighs. Cuffs are inflated to 60-80% of the participant's measured arterial occlusion pressure (AOP). Pressure is increased at Weeks 5 and 9 based on tolerance. Cuff inflation will not exceed 80% of limb occlusion pressure. Cuffs will be immediately deflated if participants' vitals suggest poor tolerance.

All BFR resistance sessions will include two standardized lower-extremity exercises: seated calf raises and standing calf raises. Each session will follow this protocol:

  1. 1 set of 30 repetitions, followed by 3 sets of 15 repetitions
  2. 30 seconds rest between sets, with the cuff remaining inflated
  3. Load set at 20-35% of 1RM
  4. Cuff deflated immediately after the fourth set or after 6 continuous minutes of inflation, whichever comes first
有源比较器:Low-Load Traditional Resistance Training (LL-RT)

Participants perform the same two calf exercises (seated and standing calf raises) without BFR cuffs. If participants demonstrate the ability to complete all prescribed repetitions without undue strain, planned load progressions of approximately 5-10% 1RM will be introduced at Weeks 5 and 9. Repetitions and sets will remain fixed to match the BFR protocol.

Two resistance exercises (seated and standing calf raises) using the same repetition structure

  1. 1 set of 30 repetitions, followed by 3 sets of 15 repetitions
  2. Load set at 20-35% of 1RM
  3. 30 seconds rest between sets
  4. No BFR cuffs will be used
有源比较器:High-Load Traditional Resistance Training (HL-RT)

Participants in this group will perform seated and standing calf raises following a more conventional strength training model. Similar to the other groups, if participants can complete their prescribed workload without excessive strain, two planned load progressions (5-10% 1RM) will be applied at Weeks 5 and 9. Repetitions and sets will remain fixed to preserve consistency in training structure across groups. This group serves as a benchmark for conventional resistance training in clinical and musculoskeletal rehabilitation populations.

Each session includes:

  1. 3 sets of 8-12 repetitions
  2. Load set at 60-70% of 1RM
  3. Rest periods of 60-90 seconds between sets
  4. No BFR cuffs will be used

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Walking Function
大体时间:Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)

Change in walking distance measured by the Six-Minute Walk Test (6MWT) from baseline to end of intervention and 3-month follow-up visit.

Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)
Quality of Life (QoL) (1)
大体时间:Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)

Change in health-related quality of life as assessed by EuroQol 5-Dimension 5-Level (EQ-5D-5L) from baseline to post-intervention and 3-month follow-up

Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)
Quality of Life (QoL) (2)
大体时间:Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)

Change in depressive symptoms as assessed by Patient Health Questionnaire-9 (PHQ-9) from baseline to post-intervention and 3-month follow-up

Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)
Quality of Life (QoL) (3)
大体时间:Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)

Change in self-reported walking function and symptom burden assessed by using REVASC-PAD Walking Questionnaire from baseline to post-intervention and 3-month follow-up

Baseline (Visit 1), post-intervention (8 to 12 weeks), and 3-month follow-up (3MF)

次要结果测量

结果测量
措施说明
大体时间
Claudication Onset Time (COT) during 6MWT
大体时间:Baseline, post-intervention (8 to 12 weeks), and 3 months post-intervention

Time to onset of claudication symptoms during 6MWT at baseline, post-intervention, and 3-month follow-up

Baseline, post-intervention (8 to 12 weeks), and 3 months post-intervention
Ratings of Perceived Exertion (RPE), Dyspnea, and Claudication Pain
大体时间:Multiple assessments from Visit 2 through end of intervention (approximately 8 to 12 weeks)

Session-based self-reported symptom ratings collected at each supervised exercise session from Visit 2 to end of intervention (approximately 8 to 12 weeks). These ratings assess exercise tolerance and symptom burden during blood flow restriction training.

Multiple assessments from Visit 2 through end of intervention (approximately 8 to 12 weeks)
Adverse Event (AE) and Serious Adverse Event (SAE) Rates
大体时间:Baseline to 3-month follow-up

Number and rate of adverse events and serious adverse events occurring during the study period.

Baseline to 3-month follow-up
Enrollment, Retention, and Adherence Rates
大体时间:Baseline to 3-month follow-up

Rates of successful enrollment, participant retention at post-intervention and 3-month follow-up, and adherence to prescribed exercise sessions

Baseline to 3-month follow-up

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年4月27日

初级完成 (估计的)

2027年4月27日

研究完成 (估计的)

2027年4月27日

研究注册日期

首次提交

2025年10月24日

首先提交符合 QC 标准的

2025年10月28日

首次发布 (实际的)

2025年10月31日

研究记录更新

最后更新发布 (实际的)

2026年11月4日

上次提交的符合 QC 标准的更新

2026年11月3日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

其他研究编号

  • 5460
  • Institutional Review Board (其他标识符:The University of Tennessee Health Science Center)

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅